This programme aims to provide students with an introduction to the molecular and cellular basis of disease and how this informs the design and manufacture of biological therapies. There will be a focus on protein and vaccine based therapeutic approaches, as well as emerging gene and cell therapies, and the personalized treatment of disease.

 

The course will provide a basic understanding of how our bodies work, and how this can change in disease. It will then consider the rationale behind the development of biotherapeutics and the design of biological drugs - with an emphasis on the processes and management involved in the largescale manufacture of protein drugs and vaccines. Participants will be introduced to the concepts associated with the personalisation of medicines, and novel applications associated with cell and gene therapies. Through a flexible online delivery, learners will benefit from pre-recorded and live webinars which facilitate an engaged learning environment while also supporting self-directed study.